Valeriy Duka

α‐Synuclein contributes to GSK‐3β‐catalyzed Tau phosphorylation in Parkinson's disease models

Tetyana Duka, Valeriy Duka, Jeffrey N. Joyce et al. · The FASEB Journal · 2009 · 261 citations · Full text

Molecular Biology, Social Sciences, Autophagy +17

Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia

Jonathan Wills, Jessica M. Jones, Thomas Haggerty et al. · Experimental Neurology · 2010 · 203 citations

Alzheimer's Disease, Dementia, Proteinopathies +12

GSK-3β dysregulation contributes to parkinson’s-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and α-synuclein

Joel J. Credle, Jessica George, J Wills et al. · Cell Death and Differentiation · 2014 · 113 citations · Full text

Neurodegenerative Diseases, ’ S-like Pathophysiology, Signal Transduction +10

Identification of the Sites of Tau Hyperphosphorylation and Activation of Tau Kinases in Synucleinopathies and Alzheimer’s Diseases

Valeriy Duka, Jae‐Hoon Lee, Joel J. Credle et al. · PLoS ONE · 2013 · 112 citations · Full text

Paraquat, but Not Maneb, Induces Synucleinopathy and Tauopathy in Striata of Mice through Inhibition of Proteasomal and Autophagic Pathways

Jonathan Wills, Joel J. Credle, Adam W. Oaks et al. · PLoS ONE · 2012 · 111 citations · Full text

Synaptic Transmission, Immunology, Neurochemical Biomarkers +22